Pot Stocks Are Getting Crushed. What You Need to Know.
Share Button

Pot Stocks Are Getting Crushed. What You Need to Know.

By CONNOR SMITH
Fri, Feb 12, 2021 5:10amGrey Clock 2 min

What goes up, must come down. But not necessarily this fast.

Canadian marijuana stocks that posted staggering gains on Wednesday fell just as fast Thursday, while U.S. multistate operators, or MSOs, were dragged down, but fared a bit better.

Tilray stock (ticker: TLRY) fell 49.7% Thursday, erasing all its gains from the prior trading day. Aphria stock (APHA) closed down 35.8%. Those companies expect to close a merger in the first half of the year. Under the deal announced in December, an investor would receive about 0.84 shares of the combined Tilray for every share of Aphria that they owned. Aurora Cannabis shares (ACB) were down 23.5%, while Canopy Growth (CGC) fell 22.1%.

ETFMG Alternative Harvest (MJ), an exchange-traded fund with exposure to the pot business, fell 24.6% from its Wednesday close. The ETF is still up about 74.5% year-to-date.

Meanwhile, Curaleaf (CURLF), a U.S. operator that lists shares over-the-counter in the U.S., fell 7.2%. Peers Green Thumb Industries (GTBIF), Cresco Labs (CRLBF), and Trulieve Cannabis (TCNNF) were down between 6% and 8%.

Canadian pot stocks, especially, have rallied in recent months on a wave of sentiment-driven gains as investors bet on positive political developments. Meanwhile, U.S. growers, which would benefit from an improved legal landscape, have lagged their competitors that operate in the smaller Canadian market.

Cantor Fitzgerald analyst Pablo Zuanic told Barron’s in an email that the recent action in pot stocks involving Reddit traders makes it hard to predict day-to-day moves, especially with the more-liquid Canadian growers.

“A look at the [GameStop] stock chart should be cautionary,” Zuanic added. “That said, we continue to think the top US MSOs are attractively valued taking a long-term view, even though they will get some of the Canadian downdraft.”

Ironically, some observers last month likened the move in GameStop (GME) to Tilray’s brief parabolic jump in 2018. The WallStreetBets forum on Reddit was recently littered with posts about pot stocks. One of the top posts Thursday morning likened the recent action in Canadian pot stocks to a casino.

Zuanic said on Wednesday that the gap in performance between U.S. and Canadian licensed producers, or LPs, could signal interest from the Robinhood crowd. Robinhood users can’t trade over-the-counter stocks on the platform.

“Sure, the news flow backdrop has also helped (the notion the US will open soon and Canadian LPs will benefit; news about exports), but we think this does not explain the big delta in Canada vs. US performance,” he said. “We wonder if the average RH retail investor knows the difference between an MSO and an LP, and the very different fundamentals of both cannabis markets.”

Ihor Dusaniwsky, a managing director at short-selling analytics firm S3 Partners, noted on Wednesday that there’s also a short-selling angle at play. Tilray began the year with short interest at about 48% of shares available for trading, according to S3 Partners. S3 estimates a recent short interest at 23% of shares available for trading, implying a large amount of covering, which helps drive prices up.

Short sellers sell borrowed shares with the hope they can replace the stock by purchasing it at a lower price. Dusaniwsky notes that Tilray and Cronos (CRON) saw the largest yearly decrease in short interest as a percentage of shares available for trading. He added that the top 20 cannabis shorts in the sector were down $4.32 billion in net-of-financing mark-to-market losses in 2021 by Wednesday.

“The yearlong rally has spurred short squeezes in most of the top 20 most shorted stocks in the sector and we should see the squeezes continuing, especially if the potential for nationwide U.S. cannabis legalization continues to increase,” Dusaniwsky added.

As with GameStop, the traditional buy-and-hold investor might want to stay away until things cool down.



MOST POPULAR

What a quarter-million dollars gets you in the western capital.

Alexandre de Betak and his wife are focusing on their most personal project yet.

Related Stories
Money
China’s Troubles Are Hitting Home for U.S. Companies
By RESHMA KAPADIA 05/09/2024
Money
Boeing Stock Got Hammered. Why This Analyst Downgrade Terrified Investors.
By 04/09/2024
Money
How to Lose Money on the World’s Most Popular Investment Theme
By JAMES MACKINTOSH 02/09/2024

Multinationals like Starbucks and Marriott are taking a hard look at their Chinese operations—and tempering their outlooks.

By RESHMA KAPADIA
Thu, Sep 5, 2024 4 min

For years, global companies showcased their Chinese operations as a source of robust growth. A burgeoning middle class, a stream of people moving to cities, and the creation of new services to cater to them—along with the promise of the further opening of the world’s second-largest economy—drew companies eager to tap into the action.

Then Covid hit, isolating China from much of the world. Chinese leader Xi Jinping tightened control of the economy, and U.S.-China relations hit a nadir. After decades of rapid growth, China’s economy is stuck in a rut, with increasing concerns about what will drive the next phase of its growth.

Though Chinese officials have acknowledged the sputtering economy, they have been reluctant to take more than incremental steps to reverse the trend. Making matters worse, government crackdowns on internet companies and measures to burst the country’s property bubble left households and businesses scarred.

Lowered Expectations

Now, multinational companies are taking a hard look at their Chinese operations and tempering their outlooks. Marriott International narrowed its global revenue per available room growth rate to 3% to 4%, citing continued weakness in China and expectations that demand could weaken further in the third quarter. Paris-based Kering , home to brands Gucci and Saint Laurent, posted a 22% decline in sales in the Asia-Pacific region, excluding Japan, in the first half amid weaker demand in Greater China, which includes Hong Kong and Macau.

Pricing pressure and deflation were common themes in quarterly results. Starbucks , which helped build a coffee culture in China over the past 25 years, described it as one of its most notable international challenges as it posted a 14% decline in sales from that business. As Chinese consumers reconsidered whether to spend money on Starbucks lattes, competitors such as Luckin Coffee increased pressure on the Seattle company. Starbucks executives said in their quarterly earnings call that “unprecedented store expansion” by rivals and a price war hurt profits and caused “significant disruptions” to the operating environment.

Executive anxiety extends beyond consumer companies. Elevator maker Otis Worldwide saw new-equipment orders in China fall by double digits in the second quarter, forcing it to cut its outlook for growth out of Asia. CEO Judy Marks told analysts on a quarterly earnings call that prices in China were down roughly 10% year over year, and she doesn’t see the pricing pressure abating. The company is turning to productivity improvements and cost cutting to blunt the hit.

Add in the uncertainty created by deteriorating U.S.-China relations, and many investors are steering clear. The iShares MSCI China exchange-traded fund has lost half its value since March 2021. Recovery attempts have been short-lived. undefined undefined And now some of those concerns are creeping into the U.S. market. “A decade ago China exposure [for a global company] was a way to add revenue growth to our portfolio,” says Margaret Vitrano, co-manager of large-cap growth strategies at ClearBridge Investments in New York. Today, she notes, “we now want to manage the risk of the China exposure.”

Vitrano expects improvement in 2025, but cautions it will be slow. Uncertainty over who will win the U.S. presidential election and the prospect of higher tariffs pose additional risks for global companies.

Behind the Malaise

For now, China is inching along at roughly 5% economic growth—down from a peak of 14% in 2007 and an average of about 8% in the 10 years before the pandemic. Chinese consumers hit by job losses and continued declines in property values are rethinking spending habits. Businesses worried about policy uncertainty are reluctant to invest and hire.

The trouble goes beyond frugal consumers. Xi is changing the economy’s growth model, relying less on the infrastructure and real estate market that fueled earlier growth. That means investing aggressively in manufacturing and exports as China looks to become more self-reliant and guard against geopolitical tensions.

The shift is hurting western multinationals, with deflationary forces amid burgeoning production capacity. “We have seen the investment community mark down expectations for these companies because they will have to change tack with lower-cost products and services,” says Joseph Quinlan, head of market strategy for the chief investment office at Merrill and Bank of America Private Bank.

Another challenge for multinationals outside of China is stiffened competition as Chinese companies innovate and expand—often with the backing of the government. Local rivals are upping the ante across sectors by building on their knowledge of local consumer preferences and the ability to produce higher-quality products.

Some global multinationals are having a hard time keeping up with homegrown innovation. Auto makers including General Motors have seen sales tumble and struggled to turn profitable as Chinese car shoppers increasingly opt for electric vehicles from BYD or NIO that are similar in price to internal-combustion-engine cars from foreign auto makers.

“China’s electric-vehicle makers have by leaps and bounds surpassed the capabilities of foreign brands who have a tie to the profit pool of internal combustible engines that they don’t want to disrupt,” says Christine Phillpotts, a fund manager for Ariel Investments’ emerging markets strategies.

Chinese companies are often faster than global rivals to market with new products or tweaks. “The cycle can be half of what it is for a global multinational with subsidiaries that need to check with headquarters, do an analysis, and then refresh,” Phillpotts says.

For many companies and investors, next year remains a question mark. Ashland CEO Guillermo Novo said in an August call with analysts that the chemical company was seeing a “big change” in China, with activity slowing and competition on pricing becoming more aggressive. The company, he said, was still trying to grasp the repercussions as it has created uncertainty in its 2025 outlook.

Sticking Around

Few companies are giving up. Executives at big global consumer and retail companies show no signs of reducing investment, with most still describing China as a long-term growth market, says Dana Telsey, CEO of Telsey Advisory Group.

Starbucks executives described the long-term opportunity as “significant,” with higher growth and margin opportunities in the future as China’s population continues to move from rural to suburban areas. But they also noted that their approach is evolving and they are in the early stages of exploring strategic partnerships.

Walmart sold its stake in August in Chinese e-commerce giant JD.com for $3.6 billion after an eight-year noncompete agreement expired. Analysts expect it to pump the money into its own Sam’s Club and Walmart China operation, which have benefited from the trend toward trading down in China.

“The story isn’t over for the global companies,” Phillpotts says. “It just means the effort and investment will be greater to compete.”

Corrections & Amplifications

Joseph Quinlan is head of market strategy for the chief investment office at Merrill and Bank of America Private Bank. An earlier version of this article incorrectly used his old title.